NCT00035295View on ClinicalTrials.gov

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061)

PHASE3CompletedINTERVENTIONAL
Enrollment

584

Participants

Timeline

Start Date

November 8, 2001

Primary Completion Date

December 5, 2003

Study Completion Date

December 5, 2003

Conditions
Major Depressive Disorder
Interventions
DRUG

MK0869, aprepitant

DRUG

Comparator: placebo

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00035295 - Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061) | Biotech Hunter | Biotech Hunter